Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient.
about
Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applicationsAmyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation.Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.Truncated and modified amyloid-beta species.Clinical applications of MS-based protein quantification.Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Emergence of the Solution to an Important Unmet Need.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.Evolving Relevance of Neuroproteomics in Alzheimer's Disease.Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.
P2860
Q26995267-8F5BADBE-236F-407B-9115-88CE1C28A220Q27333145-55F1C0DF-7B07-45C0-9CBF-DB7852CC957AQ38210117-B69CF187-A58E-47C0-A50B-32C62DAB8192Q38230390-F38361B0-A40C-424B-AD78-32757F8C3C4FQ38802991-EF0C3BD2-108D-4419-90FE-A2A29A87A5C9Q39341047-AB2D2A08-16E5-4D64-8158-32DAD682E544Q47407570-2DD6C535-BAE1-493B-B276-FCA76A12853DQ50999408-6C2547EC-09EA-4741-8F62-6572AC4DC618Q55456183-000F76D3-028C-4EFB-B820-3424CFA5108A
P2860
Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Evaluation of the performance ...... from the cell to the patient.
@ast
Evaluation of the performance ...... from the cell to the patient.
@en
Evaluation of the performance ...... from the cell to the patient.
@nl
type
label
Evaluation of the performance ...... from the cell to the patient.
@ast
Evaluation of the performance ...... from the cell to the patient.
@en
Evaluation of the performance ...... from the cell to the patient.
@nl
prefLabel
Evaluation of the performance ...... from the cell to the patient.
@ast
Evaluation of the performance ...... from the cell to the patient.
@en
Evaluation of the performance ...... from the cell to the patient.
@nl
P2860
P50
P356
P1476
Evaluation of the performance ...... from the cell to the patient.
@en
P2093
Mikael K Gustavsson
Ulf Andreasson
P2860
P304
P356
10.1159/000334537
P577
2012-02-01T00:00:00Z